We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Smith and Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | Ordinary Shares USD0.20 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.50 | 0.84% | 1,140.00 | 1,137.00 | 1,137.50 | 1,149.50 | 1,129.00 | 1,129.00 | 2,408,389 | 16:35:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Health Care | 6.16B | 625M | 0.720876 | 21.02 | 9.67B |
Smith & Nephew plc
Admission to Trading
In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market sourcebook 1.5.2 and 1.5.3R, Smith & Nephew plc notifies the market that the following debt securities have been admitted to trading:
|
Issuer name:
|
Smith & Nephew plc |
|
Issuer LEI:
|
213800ZTMDN8S67S1H61 |
|
Regulated market on which the securities have been admitted to trading:
|
Main Market of the London Stock Exchange plc |
|
Name, type and ISIN of the securities:
|
EUR 500,000,000 4.250 per cent. Notes due 3 June 2038 (ISIN XS3384821834) issued under Smith & Nephew plc's U.S.$5,000,000,000 Euro Medium Term Note Programme |
|
Number of securities admitted to trading:
|
EUR 500,000,000 in aggregate nominal amount |
|
Date of admission to trading:
|
3 June 2026
|
|
Date of Prospectus relating to the securities: |
Each of the base prospectus dated 17 March 2026 and the supplemental prospectus dated 15 May 2026 (together, the "Prospectus") under which the securities have been issued is available at:
https://smith-nephew.stylelabs.cloud/api/public/content/80866ebbfd2a42a797b41d878b374f70?v=a80c272c
https://smith-nephew.stylelabs.cloud/api/public/content/4fb968a0ffd1450b8ae4158c7069fbab?v=9f3a10c1
|
|
Final Terms available for viewing:
|
https://www.smith-nephew.com/en/who-we-are/investors#emtn-programme
|
For further information, please contact:
Investor contacts
|
Emily Heaven, Smith+Nephew +44 (0) 7811 919437 |
|
|
Craig Bijou, Smith+Nephew +1 (475) 850-8282 |
|
|
|
|
|
Media contacts |
|
|
Charles Reynolds, Smith+Nephew +44 (0) 1923 477314 |
|
Disclaimer - Intended Addressees
Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus or the Final Terms, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
1 Year Smith and Nephew Chart |
1 Month Smith and Nephew Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Premium
